HEADER VIRAL PROTEIN 18-SEP-14 2MUV TITLE NOE-BASED MODEL OF THE INFLUENZA A VIRUS M2 (19-49) BOUND TO DRUG 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 19-49; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 4 ORGANISM_TAXID: 499433 KEYWDS DRUG DESIGN, M2, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Y.WU,J.WANG,W.DEGRADO REVDAT 3 14-JUN-23 2MUV 1 REMARK SEQADV REVDAT 2 14-JAN-15 2MUV 1 JRNL REVDAT 1 24-DEC-14 2MUV 0 JRNL AUTH Y.WU,B.CANTURK,H.JO,C.MA,E.GIANTI,M.L.KLEIN,L.H.PINTO, JRNL AUTH 2 R.A.LAMB,G.FIORIN,J.WANG,W.F.DEGRADO JRNL TITL FLIPPING IN THE PORE: DISCOVERY OF DUAL INHIBITORS THAT BIND JRNL TITL 2 IN DIFFERENT ORIENTATIONS TO THE WILD-TYPE VERSUS THE JRNL TITL 3 AMANTADINE-RESISTANT S31N MUTANT OF THE INFLUENZA A VIRUS M2 JRNL TITL 4 PROTON CHANNEL. JRNL REF J.AM.CHEM.SOC. V. 136 17987 2014 JRNL REFN ISSN 0002-7863 JRNL PMID 25470189 JRNL DOI 10.1021/JA508461M REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE, X-PLOR NIH REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRPIPE), SCHWIETERS, KUSZEWSKI, TJANDRA AND REMARK 3 CLORE (X-PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MUV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000104073. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313 REMARK 210 PH : 6.8 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM VANIG SELECTIVE LABELING REMARK 210 PROTEIN, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 ASP C 24 150.12 -47.74 REMARK 500 4 SER A 23 130.09 64.46 REMARK 500 4 ASP A 24 105.88 -44.06 REMARK 500 4 SER B 23 130.06 64.27 REMARK 500 4 ASP B 24 105.94 -44.18 REMARK 500 4 SER C 23 130.08 64.40 REMARK 500 4 ASP C 24 106.09 -44.21 REMARK 500 4 SER D 23 130.11 64.23 REMARK 500 4 ASP D 24 106.15 -44.28 REMARK 500 7 SER A 23 83.46 -68.36 REMARK 500 7 SER B 23 83.53 -68.37 REMARK 500 7 SER C 23 83.55 -68.56 REMARK 500 7 SER D 23 83.61 -68.54 REMARK 500 9 SER A 23 84.56 -66.68 REMARK 500 9 SER B 23 84.41 -66.70 REMARK 500 9 SER C 23 84.57 -66.75 REMARK 500 9 SER D 23 84.72 -66.83 REMARK 500 11 SER A 23 21.93 49.70 REMARK 500 11 ASP A 24 106.69 -44.85 REMARK 500 11 SER B 23 21.89 49.74 REMARK 500 11 ASP B 24 106.57 -44.70 REMARK 500 11 SER C 23 22.09 49.64 REMARK 500 11 ASP C 24 106.61 -44.91 REMARK 500 11 SER D 23 22.02 49.56 REMARK 500 11 ASP D 24 106.63 -44.74 REMARK 500 12 SER A 23 87.01 -65.01 REMARK 500 12 SER B 23 86.79 -64.86 REMARK 500 12 ASP B 24 150.16 -49.97 REMARK 500 12 SER C 23 86.91 -65.01 REMARK 500 12 ASP C 24 150.09 -49.91 REMARK 500 12 SER D 23 86.98 -64.93 REMARK 500 15 PHE A 47 1.44 -68.11 REMARK 500 15 PHE B 47 1.28 -67.93 REMARK 500 15 PHE C 47 1.43 -68.12 REMARK 500 15 PHE D 47 1.37 -67.90 REMARK 500 16 PHE A 47 -64.77 -91.29 REMARK 500 16 PHE B 47 -64.78 -91.23 REMARK 500 16 PHE C 47 -64.91 -91.28 REMARK 500 16 PHE D 47 -64.68 -91.32 REMARK 500 20 ASP A 24 104.35 -42.24 REMARK 500 20 ASP B 24 104.32 -42.22 REMARK 500 20 ASP C 24 104.28 -42.15 REMARK 500 20 ASP D 24 104.25 -42.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3LW C 100 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25233 RELATED DB: BMRB REMARK 900 RELATED ID: 2MUW RELATED DB: PDB DBREF 2MUV A 19 49 UNP B0LX40 B0LX40_9INFA 19 49 DBREF 2MUV B 19 49 UNP B0LX40 B0LX40_9INFA 19 49 DBREF 2MUV C 19 49 UNP B0LX40 B0LX40_9INFA 19 49 DBREF 2MUV D 19 49 UNP B0LX40 B0LX40_9INFA 19 49 SEQADV 2MUV SER A 19 UNP B0LX40 CYS 19 CONFLICT SEQADV 2MUV SER B 19 UNP B0LX40 CYS 19 CONFLICT SEQADV 2MUV SER C 19 UNP B0LX40 CYS 19 CONFLICT SEQADV 2MUV SER D 19 UNP B0LX40 CYS 19 CONFLICT SEQRES 1 A 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 A 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 A 31 ARG LEU PHE PHE LYS SEQRES 1 B 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 B 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 B 31 ARG LEU PHE PHE LYS SEQRES 1 C 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 C 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 C 31 ARG LEU PHE PHE LYS SEQRES 1 D 31 SER ASN ASP SER SER ASP PRO LEU VAL VAL ALA ALA ASN SEQRES 2 D 31 ILE ILE GLY ILE LEU HIS LEU ILE LEU TRP ILE LEU ASP SEQRES 3 D 31 ARG LEU PHE PHE LYS HET 3LW C 100 39 HETNAM 3LW (3S,5S,7S)-N-[(5-BROMOTHIOPHEN-2-YL) HETNAM 2 3LW METHYL]TRICYCLO[3.3.1.1~3,7~]DECAN-1-AMINIUM FORMUL 5 3LW C15 H21 BR N S 1+ HELIX 1 1 ASP A 24 PHE A 48 1 25 HELIX 2 2 ASP B 24 PHE B 48 1 25 HELIX 3 3 ASP C 24 PHE C 48 1 25 HELIX 4 4 ASP D 24 PHE D 48 1 25 SITE 1 AC1 3 VAL C 27 ALA C 30 VAL D 27 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1